Cardiopulmonary bypass induces the synthesis and release of matrix metalloproteinases

Annals of Thoracic Surgery

Volumn 71, Issue 5, 2001, Pages 1518-1523

  Joffs, Cassandra ^a   Gunasinghe, Himali R ^a   Multani, Marlina M ^a   Dorman, B Hugh ^a   Kratz, John M ^a   Crumbley III, A Jackson ^a   Crawford Jr , Fred A ^a   Spinale, Francis G ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE 3; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; NEUTROPHIL COLLAGENASE;

ADULT; ARTICLE; BASEMENT MEMBRANE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; ENZYME SYNTHESIS; EXTRACELLULAR MATRIX; FEMALE; HEART MUSCLE REVASCULARIZATION; HOMEOSTASIS; HUMAN; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL;

AGED; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS; ENZYME INDUCTION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED;

EID: 0034996905     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(01)02442-0     Document Type: Article

References (26)

1. Messent M., Sinclair D.G., Quinlan G.J., Mumby S.E., Gutteridge J.M.C., Evans T.W. Pulmonary vascular permeability after cardiopulmonary bypass and its relationship to oxidative stress. Crit Care Med. 25:1997;425-429.
2. Smith E.E.J., Naftel D.C., Blackstone E.H., Kirklin J.W. Microvascular permeability after cardiopulmonary bypass. J Thorac Cardiovasc Surg. 94:1987;225-233.
3. Edmunds L.H. Jr. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg. 66:1998;S12-S16.
4. Downing S.W., Edmunds L.H. Jr. Release of vasoactive substances during cardiopulmonary bypass. Ann Thorac Surg. 54:1992;1236-1243.
5. Galis Z.S., Sukhova G.K., Kranzhofer R., Clark S., Libby P. Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. Proc Natl Acad Sci. 92:1995;402-406.
6. Nikkari S.T., O'Brien K.D., Ferguson M., et al. Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis. Circulation. 92:1995;1393-1398.
7. Arroyo L.H., Lee R.T. Mechanisms of plaque rupture mechanical and biologic interactions . Cardiovasc Res. 41:1999;369-375.
8. Dollery C.M., McEwan J.R., Henney A.M. Matrix metalloproteinases and cardiovascular disease. Circ Res. 77:1995;863-868.
9. Kai H., Ikeda H., Yasukawa H., et al. Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes. J Am Coll Cardiol. 32:1998;368-372.
10. Sukhova G.K., Schonbeck U., Rabkin E., et al. Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. Circulation. 99:2000;2503-2509.
11. Galis Z.M., Muszynski M., Sukhova G., et al. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ Res. 75:1994;181-189.
12. Herron G., Werb Z., Dwyer K., Banda M. Secretion of metalloproteinases by stimulated capillary endothelial cells. J Biol Chem. 261:1986;2810-2813.
13. Ries C., Petrides P.E. Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease. Biol Chem Hoppe Seyler. 376:1995;345-355.
14. Spinale F.G., Coker M.L., Heung L.J., et al. A matrix metalloproteinases induction/activation system exists in human left ventricular myocardium and is upregulated in heart failure. Circulation. 102:2000;1944-1949.
15. Birkedal-Hansen H., Moore W.G.I., Bodden M.K., et al. Matrix metalloproteinases a review . Crit Rev Oral Biol Med. 4:1993;197-250.
16. Parsons S.L., Watson S.A., Brown P.D., Collins H.M., Steele R.J.C. Matrix metalloproteinases. Brit J Surg. 84:1997;160-166.
17. Streuli C. Extracellular matrix remodeling and cellular differentiation. Curr Opin Cell Biol. 11:1999;634-640.
18. Spinale F.G., Coker M.L., Bond B.R., Zellner J.L. Myocardial matrix metalloproteinases activation in the failing heart a potential therapeutic target . Cardiovasc Res. 46:2000;225-238.
19. Jeffrey J.J. Interstitial collagenases. Parks W.C., Mecham R.P. Matrix metalloproteinases. 1998;15-42 Academic Press, San Diego.
20. Fini E., Cook J.R., Mohan R., Brinckerhoff C.E. Regulation of matrix metalloproteinases gene expression. Parks W.C., Mecham R.P. Matrix metalloproteinases. 1998;299-356 Academic Press, San Diego.
21. Dauber I.M., Parsons P.E., Welsh C.H., et al. Peripheral bypass-induced pulmonary and coronary vascular injury - association with increased levels of tumor necrosis factor. Circulation. 88:1993;726-735.
22. Dewanjee M.K., Wu S.M., Burke G.W. III, Hsu L.C. Tumor necrosis factor-alpha during cardiopulmonary bypass in a pig model correlation with marginated neutrophils and cerebral edema by magnetic resonance imaging . ASAIO. 44:1998;212-218.
23. Nagase H. Activational mechanisms of matrix metalloproteinases. Biol Chem. 378:1997;151-160.
24. Coker M.L., Doscher M.A., Thomas C.V., Galis Z.A., Spinale F.G. Matrix metalloproteinase synthesis and expression in isolated LV myocyte preparations. Am J Physiol (Heart Circ Physiol 46). 227:1999;H777-H787.
25. Cox C.S. Jr, Allen S.J., Brennan M. Analysis of intestinal microvascular permeability associated with cardiopulmonary bypass. J Surg Res. 83:1999;19-26.
26. Spencer-Green G. Etanercept (Enbrel) update on therapeutic use . Ann Rheum Dis. 59:2000;I46-I49.